ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. (“Company” or “Alliança”) (B3: AALR3), in accordance with the provisions of art. 157, 4th paragraph of Law No. 6,404 of December 15, 1976, as amended (“Corporations Law”) and in CVM Resolution No. 44, of August 23, 2021, as amended, informs its shareholders and the market in general that, on March 17th, 2025, received a notification from the controlling shareholder Lormont Participações S.A., communicating the irrevocable and irreversible interest in using credit in the total amount of R$ 310,298,700.70 (three hundred and ten million, two hundred and ninety-eight thousand, seven hundred reais and seventy centavos) (“Credit”) in a future increase in the Company’s share capital.
The Credit arises from the offsetting of credits acquired by Lormont directly from the FUNDO DE INVESTIMENTO EM DIREITOS CREDITÓRIOS SAÚDE & IMAGEM – RESPONSABILIDADE LIMITADA (“FIDC”
or “Fund”) against Alliança, in the total amount of R$338,755,221.75 (three hundred and thirty-eight million, seven hundred and fifty-five thousand, two hundred and twenty-one reais and seventy-five centavos), as well as assumption by Lormont of the FIDC’s obligation to pay the premium to Alliança, in the amount of R$ 28,456,521.00 (twenty-eight million, four hundred and fifty-six thousand, five hundred and twenty-one reais).
The Company informs that it will take, in due course, all necessary measures for the approval and implementation of the capital increase through capitalization of the Credit, as well as will keep its shareholders and the market duly informed about any relevant developments related to the capitalization of the Credit, in accordance with applicable legislation.
São Paulo, March 17th, 2025.
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.